🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 14 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/08/2021 | 179,73 | 181,21 | 177,82 | 180,66 | +0,44% | 1,89% | 401.700 |
| 02/08/2021 | 183,40 | 183,48 | 179,40 | 179,86 | -1,14% | 2,22% | 385.900 |
| 30/07/2021 | 182,90 | 184,64 | 181,13 | 181,93 | -1,24% | 1,92% | 206.200 |
| 29/07/2021 | 186,27 | 188,64 | 184,05 | 184,22 | -0,67% | 2,46% | 131.400 |
| 28/07/2021 | 185,25 | 186,53 | 184,22 | 185,46 | -0,47% | 1,25% | 169.000 |
| 27/07/2021 | 182,58 | 186,55 | 180,05 | 186,34 | +1,68% | 3,56% | 187.700 |
| 26/07/2021 | 184,57 | 185,71 | 182,38 | 183,27 | -0,70% | 1,80% | 169.100 |
| 23/07/2021 | 185,92 | 187,91 | 184,24 | 184,57 | -0,66% | 1,97% | 184.400 |
| 22/07/2021 | 181,76 | 186,15 | 180,92 | 185,79 | +1,65% | 2,88% | 200.500 |
| 21/07/2021 | 185,18 | 185,88 | 182,32 | 182,78 | -0,91% | 1,92% | 161.100 |
| 20/07/2021 | 183,59 | 187,72 | 182,84 | 184,45 | +0,62% | 2,66% | 272.100 |
| 19/07/2021 | 183,90 | 184,94 | 180,28 | 183,32 | -0,90% | 2,53% | 215.300 |
| 16/07/2021 | 184,84 | 186,70 | 182,94 | 184,99 | +0,43% | 2,03% | 229.100 |
| 15/07/2021 | 182,78 | 185,07 | 180,96 | 184,19 | +0,33% | 2,25% | 171.700 |
| 14/07/2021 | 188,20 | 188,20 | 182,49 | 183,59 | +0,02% | 3,03% | 180.800 |
| 13/07/2021 | 184,83 | 187,16 | 183,32 | 183,55 | -1,20% | 2,08% | 175.400 |
| 12/07/2021 | 187,29 | 188,07 | 185,13 | 185,78 | -1,00% | 1,57% | 189.300 |
| 09/07/2021 | 185,57 | 188,63 | 185,36 | 187,65 | +1,99% | 1,76% | 199.100 |
| 08/07/2021 | 184,06 | 186,83 | 182,76 | 183,98 | -1,60% | 2,21% | 227.200 |
| 07/07/2021 | 183,96 | 187,99 | 180,62 | 186,98 | +0,92% | 4,01% | 360.900 |
| 06/07/2021 | 184,79 | 186,29 | 182,66 | 185,27 | +0,51% | 1,96% | 353.800 |
| 02/07/2021 | 184,25 | 185,04 | 183,02 | 184,33 | -0,18% | 1,10% | 168.700 |
| 01/07/2021 | 179,97 | 185,51 | 178,75 | 184,67 | +2,93% | 3,76% | 439.200 |
| 30/06/2021 | 176,35 | 179,91 | 176,35 | 179,41 | +1,36% | 2,02% | 289.800 |
| 29/06/2021 | 176,01 | 178,00 | 175,76 | 177,00 | -0,10% | 1,27% | 190.900 |
| 28/06/2021 | 181,00 | 182,15 | 174,46 | 177,18 | -1,57% | 4,25% | 289.100 |
| 25/06/2021 | 175,75 | 181,64 | 173,76 | 180,00 | +2,42% | 4,48% | 608.800 |
| 24/06/2021 | 175,44 | 176,69 | 173,56 | 175,75 | +0,64% | 1,78% | 402.500 |
| 23/06/2021 | 180,59 | 182,55 | 173,33 | 174,64 | -3,44% | 5,11% | 299.700 |
| 22/06/2021 | 179,67 | 181,82 | 179,21 | 180,86 | +0,37% | 1,45% | 212.100 |